US/Atlanta: The US Centers for Disease Control and Prevention (“CDC”), an Atlanta, Georgia based health promotion and disease prevention authority, issues a Health Advisory against the use of certain batch/lots of EzriCare Artificial Tears due to suspected multi-state infections with an extensively drug-resistant strain of Verona Integron-mediated Metallo-β-lactamase (“VIM”) and Guiana-Extended Spectrum-β-Lactamase (“GES”)-producing Carbapenem-resistant Pseudomonas Aeruginosa (VIM-GES-CRPA) and consequential risks of bacterial infection, severe illness and/or possible life-changing complications including visual impairment and/or blindness, all serious and potential fatal hazards, requiring immediate medical intervention to minimize pain and suffering as well as prevent life-altering injury or death.
Additional information:
The US Centers for Disease Control and Prevention (“CDC”) reports the following Drugs are subject to this Health Advisory:
Filed under: Bacterial or viral contamination, Dietary Supplements, Food & Drink, Probiotics, Pseudomonas aeruginosa [Gram-neg], US CDC, US FDA | Tagged: bacterial contamination hazard, Carbapenem-resistant Pseudomonas Aeruginosa, CDC, CDC Alert: CDCHAN-00485, Centers for Disease Control and Prevention, Cornea Infection, drug, Endophthalmitis, eye drops, FDA, Health Advisory, Keratitis, Pseudomonas aeruginosa, Pseudomonas aeruginosa contamination hazard, Recalls Direct RIN: 16748-2023, respiratory infection, Sepsis, suspected bacterial contamination, Urinary Tract Infection, US FDA, US Food and Drug Administration, vision loss | Leave a comment »